Related Experiment Video

Updated: May 23, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

9.1K

[Anticancer drug research in Hungary, 1950-2000]

András Jeney1, Judit Kralovánszky1, Károly Lapis1

  • 1I. Sz. Patológiai és Kísérleti Rákkutató Intézet, Semmelweis Egyetem, Budapest, Hungary. ajeney@korb1.sote.hu.

Magyar Onkologia
|December 20, 2017
PubMed

Insights

Hungarian researchers explored anticancer drug mechanisms, revealing potential treatments like Myelobromol for leukemia and Mitolactol for brain tumors. Understanding drug action is key to developing new cancer therapies.

Area of Science:

  • Oncology
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Anticancer drug research is crucial for effective cancer treatment.
  • Understanding the mode of action of these drugs can reveal new therapeutic applications.

Purpose of the Study:

  • To review the history of anticancer drug research in Hungary.
  • To highlight the importance of studying the mode of action of anticancer compounds.
  • To discuss specific drug classes and their mechanisms.

Main Methods:

  • Review of historical research and scientific literature.
  • Detailed investigation of the mode of action for selected compounds.
  • Analysis of clinical applications and therapeutic potential.

Main Results:

  • Myelobromol shows selective action against myeloid elements, useful in chronic myeloid leukemia and bone marrow ablation.
  • Mitolactol can cross the blood-brain barrier, indicating potential for treating brain tumors.
  • 5-ethyl-2'-deoxyuridine enhances 5-fluorouracil efficacy by inhibiting dihydropyrimidine dehydrogenase.
  • 5-hexil-2'-deoxyuridine prevents metastasis by inhibiting the glycoconjugate pathway and heparan sulfate production.
  • Vinca alkaloids, antiestrogens, and GNRH analogues demonstrate significant effects.

Conclusions:

  • Studies on the mode of action are vital for discovering clinically useful oncopharmacological properties.
  • Specific Hungarian research has yielded promising anticancer agents with diverse mechanisms.
  • Further investigation into drug mechanisms can lead to improved cancer therapies.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...